Literature DB >> 8499040

Multiple syndromes of 3-methylglutaconic aciduria.

K M Gibson1, O N Elpeleg, C Jakobs, H Costeff, R I Kelley.   

Abstract

The most common clinical syndromes associated with 3-methylglutaconic aciduria are presented. In some patients these syndromes are multisystemic, progressive disorders of unknown etiology. Tissues deriving significant energy through oxidative metabolism (notably brain and cardiac muscle) are most often affected and in some the primary defect may reside within the mitochondrial respiratory chain. Although increasing biochemical evidence suggests that 3-methylglutaconic aciduria may correlate with deranged mitochondrial energy metabolism, the biochemical origin of 3-methylglutaconic acid and the significance of its increased excretion remain unknown. This review describes these syndromes and illustrates the necessity of urinary organic acid analysis to assist in the differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8499040     DOI: 10.1016/0887-8994(93)90046-f

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  22 in total

1.  3-Methylglutaconic aciduria and hypermethioninaemia in a child with clinical and neuroradiological findings of Leigh disease.

Authors:  M Di Rocco; U Caruso; I Moroni; S Lupino; E Lamantea; A R Fantasia; C Borrone; K M Gibson
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  3-Methylglutaconic aciduria type I: clinical heterogeneity as a neurometabolic disease.

Authors:  Y Shoji; T Takahashi; Y Sawaishi; A Ishida; M Matsumori; Y Shoji; M Enoki; H Watanabe; G Takada
Journal:  J Inherit Metab Dis       Date:  1999-02       Impact factor: 4.982

3.  3-Methylglutaconyl-CoA hydratase deficiency: a new patient with speech retardation as the leading sign.

Authors:  R Ensenauer; C B Müller; K O Schwab; K M Gibson; M Brandis; W Lehnert
Journal:  J Inherit Metab Dis       Date:  2000-06       Impact factor: 4.982

4.  Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews.

Authors:  Y Anikster; R Kleta; A Shaag; W A Gahl; O Elpeleg
Journal:  Am J Hum Genet       Date:  2001-10-19       Impact factor: 11.025

5.  Variable clinical presentation in three patients with 3-methylglutaconyl-coenzyme A hydratase deficiency.

Authors:  K M Gibson; R S Wappner; S Jooste; E Erasmus; L J Mienie; E Gerlo; B Desprechins; L De Meirleir
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

6.  OPA3, mutated in 3-methylglutaconic aciduria type III, encodes two transcripts targeted primarily to mitochondria.

Authors:  Marjan Huizing; Heidi Dorward; Lien Ly; Enriko Klootwijk; Robert Kleta; Flemming Skovby; Wuhong Pei; Benjamin Feldman; William A Gahl; Yair Anikster
Journal:  Mol Genet Metab       Date:  2010-03-16       Impact factor: 4.797

7.  Hypertrophic cardiomyopathy, cataract, developmental delay, lactic acidosis: a novel subtype of 3-methylglutaconic aciduria.

Authors:  Gabriella Di Rosa; Federica Deodato; Ference J Loupatty; Cristiano Rizzo; Rosalba Carrozzo; Filippo M Santorelli; Sara Boenzi; Adele D'Amico; Giulia Tozzi; Enrico Bertini; Andrea Maiorana; Ronald J A Wanders; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2006-05-30       Impact factor: 4.982

8.  A model of Costeff Syndrome reveals metabolic and protective functions of mitochondrial OPA3.

Authors:  Wuhong Pei; Lisa E Kratz; Isa Bernardini; Raman Sood; Tohei Yokogawa; Heidi Dorward; Carla Ciccone; Richard I Kelley; Yair Anikster; Harold A Burgess; Marjan Huizing; Benjamin Feldman
Journal:  Development       Date:  2010-08-01       Impact factor: 6.868

Review 9.  Metabolic biology of 3-methylglutaconic acid-uria: a new perspective.

Authors:  Betty Su; Robert O Ryan
Journal:  J Inherit Metab Dis       Date:  2014-01-10       Impact factor: 4.982

Review 10.  Costeff optic atrophy syndrome: new clinical case and novel molecular findings.

Authors:  G Ho; J H Walter; J Christodoulou
Journal:  J Inherit Metab Dis       Date:  2008-11-07       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.